Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

C-reactive protein is essential for innate resistance to pneumococcal infection.

Simons JP, Loeffler JM, Al-Shawi R, Ellmerich S, Hutchinson WL, Tennent GA, Petrie A, Raynes JG, de Souza JB, Lawrence RA, Read KD, Pepys MB.

Immunology. 2014 Jul;142(3):414-20. doi: 10.1111/imm.12266.

2.

AA amyloidosis complicating the hereditary periodic fever syndromes.

Lane T, Loeffler JM, Rowczenio DM, Gilbertson JA, Bybee A, Russell TL, Gillmore JD, Wechalekar AD, Hawkins PN, Lachmann HJ.

Arthritis Rheum. 2013 Apr;65(4):1116-21. doi: 10.1002/art.37827.

3.

The golden fountain--is urine the miracle drug no one told you about?

Loeffler JM.

Pan Afr Med J. 2010 May 25;5:13. No abstract available.

4.

Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

Witzenrath M, Schmeck B, Doehn JM, Tschernig T, Zahlten J, Loeffler JM, Zemlin M, Müller H, Gutbier B, Schütte H, Hippenstiel S, Fischetti VA, Suttorp N, Rosseau S.

Crit Care Med. 2009 Feb;37(2):642-9. doi: 10.1097/CCM.0b013e31819586a6.

PMID:
19114881
5.

Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis.

Grandgirard D, Loeffler JM, Fischetti VA, Leib SL.

J Infect Dis. 2008 Jun 1;197(11):1519-22. doi: 10.1086/587942.

PMID:
18471063
6.

Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae.

McCullers JA, Karlström A, Iverson AR, Loeffler JM, Fischetti VA.

PLoS Pathog. 2007 Mar;3(3):e28. No abstract available.

7.
8.

A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.

Kang YS, Do Y, Lee HK, Park SH, Cheong C, Lynch RM, Loeffler JM, Steinman RM, Park CG.

Cell. 2006 Apr 7;125(1):47-58.

9.

Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats.

Entenza JM, Loeffler JM, Grandgirard D, Fischetti VA, Moreillon P.

Antimicrob Agents Chemother. 2005 Nov;49(11):4789-92.

11.
12.

Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units.

Loeffler JM, Garbino J, Lew D, Harbarth S, Rohner P.

Scand J Infect Dis. 2003;35(11-12):843-50.

PMID:
14723360
13.

The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen.

Kang YS, Kim JY, Bruening SA, Pack M, Charalambous A, Pritsker A, Moran TM, Loeffler JM, Steinman RM, Park CG.

Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):215-20. Epub 2003 Dec 23.

14.

Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia.

Loeffler JM, Djurkovic S, Fischetti VA.

Infect Immun. 2003 Nov;71(11):6199-204.

15.

Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats.

Leib SL, Heimgartner C, Bifrare YD, Loeffler JM, Täauber MG.

Pediatr Res. 2003 Sep;54(3):353-7. Epub 2003 Jun 4.

PMID:
12788989
17.

Nocardial brain abscess: observation of treatment strategies and outcome in Switzerland from 1992 to 1999.

Loeffler JM, Bodmer T, Zimmerli W, Leib SL.

Infection. 2001 Dec;29(6):337-41.

PMID:
11787836
18.

Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase.

Loeffler JM, Nelson D, Fischetti VA.

Science. 2001 Dec 7;294(5549):2170-2.

19.

Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.

Leib SL, Clements JM, Lindberg RL, Heimgartner C, Loeffler JM, Pfister LA, Täuber MG, Leppert D.

Brain. 2001 Sep;124(Pt 9):1734-42.

PMID:
11522576
20.

The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis.

Loeffler JM, Ringer R, Hablützel M, Täuber MG, Leib SL.

J Infect Dis. 2001 Jan 15;183(2):247-252. Epub 2000 Dec 8.

Supplemental Content

Loading ...
Support Center